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The Effects of Antenatal Betamethasone on Late Preterm Infants
Jennifer Hummel, DO, Abigail Prest, DO, and Xinhua Chen, MD, MSCE
Department of Obstetrics and Gynecology

Abstract
Administration of steroids to mothers expected to deliver in the late preterm
period has previously been found to decrease neonatal respiratory morbidity.
In this retrospective chart review, there were no significant differences
between groups in the primary outcome of required respiratory support for
the neonate, incidence of periventricular hemorrhage or neonatal death.
However, this study found that their rate of hyperbilirubinemia, need for
phototherapy, and NICU stays were longer than their counterparts whose
mothers did not receive steroids or who only received one dose. These
findings may provide support for future protocols directed to improve
neonatal morbidity secondary to jaundice.

Background
Antenatal glucocorticoids have been used in pregnancies at risk for early
preterm delivery since a consensus conference held by the National Institutes
of Health in 1994. The multiple studies reviewed by this conference
determined that injection of glucocorticoids reduces adverse neonatal
outcomes when given to women who are likely to deliver before 34 weeks of
gestation. In April 2016, the New England Journal of Medicine published a new
study that investigated the use of corticosteroids in late preterm pregnancies
(from 34 weeks 0 days to 36 weeks 6 days). This study demonstrated a clear
improvement in neonatal respiratory outcomes. The current study was
planned to examine whether an improvement has been made in neonatal
morbidity at Jefferson Washington Township since the providers began
administering antenatal corticosteroids to patients at risk of delivering in the
late preterm period.

Results
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Contrary to the expected outcome, this study found unchanged rates of neonatal
respiratory morbidity between infants whose mothers had received steroids and
those who did not. Instead, the fully treated group of infants was found to have
higher rates of jaundice and need for phototherapy with longer NICU stays. It is
not completely clear what may have caused this correlation. One theory is the
known effect of hyperglycemia in the mother from corticosteroids which may
have caused a reflexive polycythemia in the fetus and therefore, red blood cell
destruction and jaundice after birth. The rates of hyperbilirubinemia have been
shown to be elevated in infants given antenatal steroids in previous studies,
although whether it could be modulated by strict maternal glycemic control has
not yet been studied. The respiratory benefits demonstrated in previous studies
may outweigh the morbidity of jaundice requiring phototherapy. Further studies
are needed to possibly apply various protocols for maternal glycemic control
after steroid administration and investigate whether there is a measurable
benefit to the rates of neonatal jaundice.
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Chart 1. Comparison of Outcomes Between Treatment Groups

There were no significant differences between groups in the primary outcome.
However, there was a significantly longer length of NICU stay (P= 0.0009) and
neonatal hyperbilirubinemia (P=0.0063) in the treated group of late preterm
infants. Similarly, infants whose mothers received a full course of steroids also
had a significantly higher rate of phototherapy (P<0.001). Mothers with chronic
hypertension were more likely to have a full course of treatment (P=0.0086) as
were those with pre-eclampsia (P= 0.029) over those with other maternal
complications including gestational hypertension. These results were not found
to be altered by gestational age or time from steroid administration to delivery.
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Effects

A retrospective chart review was performed on patients and their infants born
during 34 to 36.6 weeks gestational age from May 2014 to December 2018 in
Jefferson Hospital at Washington Township. The primary objective was to assess
the newborn’s need for respiratory support within 72 hours after birth, consisting
of one or more of the following: the use of continuous positive airway pressure
(CPAP) or high-flow nasal cannula for at least 2 consecutive hours, supplemental
oxygen with a fraction of inspired oxygen of at least 0.30 for at least 4 continuous
hours, extracorporeal membrane oxygenation (ECMO), or mechanical ventilation.
Secondary objectives were the incidence of periventricular hemorrhage as seen on
CT, ultrasound or MRI, neonatal death, length of NICU stay, neonatal
hyperbilirubinemia, phototherapy, and neonatal hypoglycemia as defined as less
than 45mg/dL. A two group independent t-test was used for continuous variables
and chi-square, Fisher’s exact tests for categorical, and logistic regression analyses
were used to analyze differences between groups.

Discussion
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Special thanks to Dr. Chen for her patience & help with stats and to Dr. Hummel for
her support!
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Chart 2. Confidence Intervals of Various Effects on Infants
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